BRM-loading · layering pigment…
BRM-loading · layering pigment…
Open R&D · longevity · 4 open problems · substrate contribution paths
Open problems in longevity R&D where senolytic dropout, biomarker divergence, and metaflammation redundancy have stalled conventional progress. Each row names the structural barrier + the substrate's contribution (three-body audit + sieve inference + cross-civilizational anchor). Average time-to-impact for substrate contributions: 23 months.
cumulative annual R&D spend addressed · USD millions
v1.2026.05.16 · 4 problems · max spend $500M · block 946,772
Open-problem ledger · substrate-contribution pathways · Each row names a structurally unsolved R&D problem, the reason the conventional industry has not closed it, and the substrate contribution path the BRMSTE substrate offers. Substrate modes: physics-decomposer · sieve-inference · cross-civilizational-historical-anchor · agentic-routing · three-body-failure-audit. See /legal/liability.
| # | Open problem | Why unsolved | R&D ($M) | Substrate contribution | T-to-impact (mo) |
|---|---|---|---|---|---|
| 01 | Senolytic drug clinical validation (human dosing · safety) senolytic-clinical-validation | phase-II dropout due to off-target effects · frailty enrollment limited | 200 | three-body audit (drug pharmacology × patient frailty × adverse-event residue) + physics decomposer on drug clearance | 24 |
| 02 | Aging biomarker multi-modal integration aging-biomarker-multimodal | epigenetic × transcriptomic × proteomic clocks diverge · predictive power modest | 150 | sieve inference on biological-clock cross-validation + agentic multi-tissue integration | 15 |
| 03 | Cellular reprogramming safety validation in vivo cellular-reprogramming-safety-vivo | Yamanaka off-targets · tumorigenesis risk unmeasured | 500 | agentic per-cell monitoring (reprogramming kinetics + off-target activation) + three-body audit | 30 |
| 04 | Systemic inflammation driver mapping (metaflammation) metaflammation-driver-mapping | >50 candidate pathways · cytokine redundancy masks causality | 100 | cross-civilizational anchor (70+ years aging inflammation literature) + agentic pathway routing | 21 |
“4 open problems in Longevity · aging biology. Cumulative annual R&D spend addressed: $950M. Each row names the substrate-contribution path. The substrate publishes what it can move; counterparties verify the path before applying.”
Wave OPEN-RD · longevity · v1.2026.05.16